Ethos Veterinary Health
  • Veterinary Teams
    • Submit a Referral
    • Hospital Updates
    • Ethos Materials for Clinics
    • Continuing Education
    • Veterinary Compounding
    • VetBloom CE
    • Ethos Discovery
    • Clinical Studies
    • Emergency/Critical Care + Specialty Hospitals
    • Veterinary Urgent Care Clinics
  • Our Hospitals
    • NORTHEAST
      • Boston West
      • Bulger
      • Capital District
      • Mass Vet
      • Peak
      • Port City
      • SAVES
    • MID-ATLANTIC
      • The Oncology Service – Leesburg
      • The Oncology Service – Richmond
      • The Oncology Service – Springfield
    • MIDWEST
      • Premier – Chicago
      • Premier – Grayslake
      • Premier – Orland Park
      • WVRC – Grafton
      • WVRC – Racine/Kenosha
      • WVRC – Waukesha
    • MOUNTAIN
      • Wheat Ridge
    • PACIFIC
      • Atlantic Street
      • PESCM
      • VERC
      • Vista
      • VSH – North County
      • VSH – Sorrento Valley
      • Veterinary Urgent Care Clinics
  • Our Services
    • Continuing Education
    • Blood Donor Program
    • Ethos Discovery
    • Clinical Studies
    • FAQs: Clinical Studies at Ethos
    • VetBloom CE
    • Hospital Services
  • About Us
    • About Us
    • Why Ethos
    • Veterinary Urgent Care by Ethos
    • Ethos Discovery
    • Leadership Team
    • Press Releases
    • Contact Us
  • Blogs & Videos
    • Our Blogs
    • PAWEDCast
    • Diagnosing Inequality Podcast
  • We’re Hiring!
    • Apply Today
    • Ethos Job Fairs
    • Employee Benefits
    • Giving Back
    • Veterinary Training Programs
Ethos Veterinary Health
  • Our Hospitals
    • NORTHEAST
      • Boston West
      • Bulger
      • Capital District
      • Mass Vet
      • Peak
      • Port City
      • SAVES
    • MID-ATLANTIC
      • The Oncology Service – Leesburg
      • The Oncology Service – Richmond
      • The Oncology Service – Springfield
    • MIDWEST
      • Premier – Chicago
      • Premier – Grayslake
      • Premier – Orland Park
      • WVRC – Grafton
      • WVRC – Racine/Kenosha
      • WVRC – Waukesha
    • MOUNTAIN
      • Wheat Ridge
    • PACIFIC
      • Atlantic Street
      • PESCM
      • VERC
      • Vista
      • VSH – North County
      • VSH – Sorrento Valley
      • Veterinary Urgent Care Clinics
  • Our Services
    • Continuing Education
    • Blood Donor Program
    • Ethos Discovery
    • Clinical Studies
    • FAQs: Clinical Studies at Ethos
    • VetBloom CE
    • Hospital Services
  • About Us
    • About Us
    • Why Ethos
    • Veterinary Urgent Care by Ethos
    • Ethos Discovery
    • Leadership Team
    • Press Releases
    • Contact Us
  • Blogs & Videos
    • Our Blogs
    • PAWEDCast
    • Diagnosing Inequality Podcast
  • We’re Hiring!
    • Apply Today
    • Ethos Job Fairs
    • Employee Benefits
    • Giving Back
    • Veterinary Training Programs
  • Veterinary Teams
    • Submit a Referral
    • Hospital Updates
    • Ethos Materials for Clinics
    • Continuing Education
    • Veterinary Compounding
    • VetBloom CE
    • Ethos Discovery
    • Clinical Studies
    • Emergency/Critical Care + Specialty Hospitals
    • Veterinary Urgent Care Clinics

Clinical Studies

  • Omics Research-Based Identification of Targets in Sepsis (ORBITS)

    Currently Enrolling

    Sepsis is caused by a severe infection that enters the bloodstream and is associated with a high mortality rate. This high mortality rate has remained unchanged over the last three decades even though there has been active research in the area.

    Study Details
  • Evaluating the Tolerability of Combination of Verdinexor and Doxorubicin in Dogs with Cancer

    Currently Enrolling

    Verdinexor is a chemotherapy drug that has been conditionally approved by the FDA for the treatment of canine lymphoma. Verdinexor is a selective inhibitor of nuclear export (SINE) compound, and this family of drug has demonstrated encouraging results in preclinical studies when combined with other chemotherapeutic drugs.

    Study Details
  • Tolerability of Oral Paclitaxel in Cancer-Bearing Dogs

    Closed

    Research Type Ethos Discovery De Novo Study Description Paclitaxel is a human chemotherapeutic that has demonstrated a broad spectrum of activity against  several human and canine cancers. Previous formulations of paclitaxel have been poorly absorbed in dogs, limiting its therapeutic value. Oraxol is a novel oral formulation of paclitaxel that is combined with a second

    Study Details
  • Ethos Precision Medicine Umbrella Study for Hemangiosarcoma (Ethos-PUSH)

    Currently Enrolling

    Ethos Discovery now seeks to deliver a highly advanced clinical trial program investigating the use of novel drugs for the treatment of Hemangiosarcoma (HSA) with the goal of curing this aggressive cancer. This study will ask if drugs specifically matched to the genomic subtypes of patients with HSA will result in improved outcomes.

    Study Details
  • Dysbiosis Enhancing Linkage Towards Association with Canine Osteosarcoma (DEL-TACO Lite)

    Currently Enrolling

    Intestinal dysbiosis has been associated with tumor progression of colorectal, lung, and breast cancer in human patients. The objective of this study is to determine whether or not canine patients diagnosed with osteosarcoma have intestinal dysbiosis and if the presence of intestinal dysbiosis is associated with metastasis in these patients.

    Study Details
Ethos Veterinary Health
  • Veterinary Teams
    • Submit a Referral
    • Hospital Updates
    • Ethos Materials for Clinics
    • Continuing Education
    • Veterinary Compounding
    • VetBloom CE
    • Ethos Discovery
    • Clinical Studies
    • Emergency/Critical Care + Specialty Hospitals
    • Veterinary Urgent Care Clinics
© 2022 Ethos Veterinary Health
Website Design by Jackrabbit